Vous n'êtes pas identifié (connexion)

Centre de recherche

BOTTIN

Vincent Fradet

Formation
à venir

Aucune offre active

Autres opportunités de carrière
Axe principal
Oncologie
Adresse(s)
Hôtel-Dieu de Québec
6, rue McMahon
0622
Québec (Québec)
CANADA G1R 2J6

Téléphone(s)
+1 418-525-4444, poste 15568
Télécopieur(s)
+1 418-691-5562
Courriel(s)
vincent.fradet@fmed.ulaval.ca

Projet(s) de recherche actif(s)

Aucun projet de recherche à afficher

Publications récentes (voir toutes les publications de ce chercheur)

Morin F, Beauregard JM, Bergeron M, Nguile Maka M, Lacombe L, Fradet V, Fradet Y, Pouliot F. Metabolic Imaging of Prostate Cancer Reveals Intrapatient Intermetastasis Response Heterogeneity to Systemic Therapy European urology focus,  .  
Morin F, Beauregard JM, Bergeron M, Nguile Makao M, Lacombe L, Fradet V, Fradet Y, Pouliot F. Metabolic Imaging of Prostate Cancer Reveals Intrapatient Intermetastasis Response Heterogeneity to Systemic Therapy. European urology focus,  2017. Epub
Lacombe L, Fradet V, Levesque E, Pouliot F, Larue H, Bergeron A, Hovington H, Caron A, Nguile-Makao M, Harvey M, Fradet Y, Guillemette C. Phase II Drug-Metabolizing Polymorphisms and Smoking Predict Recurrence of Non-Muscle-Invasive Bladder Cancer: A Gene-Smoking Interaction. Cancer prevention research (Philadelphia, Pa.),  2016. 9: 189-95
Gagne-Loranger M, Lacombe L, Pouliot F, Fradet V, Dagenais F. Renal cell carcinoma with thrombus extending to the hepatic veins or right atrium: operative strategies based on 41 consecutive patients. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,  2016. 50: 317-21
Beauregard JM, Blouin AC, Fradet V, Caron A, Fradet Y, Lemay C, Lacombe L, Dujardin T, Tiguert R, Rimac G, Bouchard F, Pouliot F. FDG-PET/CT for pre-operative staging and prognostic stratification of patients with high-grade prostate cancer at biopsy. Cancer imaging : the official publication of the International Cancer Imaging Society,  2015. 15: 2
Perrault L, Fradet V, Lauzon V, LeLorier J, Mitchell D, Habib M. Burden of illness of bone metastases in prostate cancer patients in Quebec, Canada: A population-based analysis. Canadian Urological Association journal = Journal de l’Association des urologues du Canada.,  2015. 9: 307-14
Desmeules P, Hovington H, Nguile-Makao M, Leger C, Caron A, Lacombe L, Fradet Y, Tetu B, Fradet V. Comparison of digital image analysis and visual scoring of KI-67 in prostate cancer prognosis after prostatectomy. Diagnostic pathology,  2015. 10: 67
Magnan S, Zarychanski R, Pilote L, Bernier L, Shemilt M, Vigneault E, Fradet V, Turgeon AF. Intermittent vs Continuous Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-analysis. JAMA oncology,  2015. 1: 1261-9
Allaire J, Moreel X, Labonte ME, Leger C, Caron A, Julien P, Lamarche B, Fradet V. Validation of the omega-3 fatty acid intake measured by a web-based food frequency questionnaire against omega-3 fatty acids in red blood cells in men with prostate cancer. European journal of clinical nutrition,  2015. 69: 1004-8
Neveu B, Moreel X, Deschenes-Rompre MP, Bergeron A, LaRue H, Ayari C, Fradet Y, Fradet V. IL-8 secretion in primary cultures of prostate cells is associated with prostate cancer aggressiveness. Research and reports in urology,  2014. 6: 27-34
© 2017 Tous droits réservés Centre de recherche du CHU de Québec